MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies

SE Ahmadi, S Rahimi, B Zarandi, R Chegeni… - Journal of hematology & …, 2021 - Springer
MYC oncogene is a transcription factor with a wide array of functions affecting cellular
activities such as cell cycle, apoptosis, DNA damage response, and hematopoiesis. Due to …

HIV-associated cancers and related diseases

R Yarchoan, TS Uldrick - New England Journal of Medicine, 2018 - Mass Medical Soc
AIDS-Associated Cancers Cancer is a leading cause of death in patients with AIDS. The
incidence of AIDS-defining cancers has been stable owing to highly active antiretroviral …

The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications

E Campo, SH Swerdlow, NL Harris… - Blood, The Journal …, 2011 - ashpublications.org
Abstract The World Health Organization classification of lymphoid neoplasms updated in
2008 represents a worldwide consensus on the diagnosis of these tumors and is based on …

The biology and treatment of plasmablastic lymphoma

JJ Castillo, M Bibas, RN Miranda - Blood, The Journal of the …, 2015 - ashpublications.org
Plasmablastic lymphoma (PBL) is an aggressive lymphoma commonly associated with HIV
infection. However, PBL can also be seen in patients with other immunodeficiencies as well …

HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus

KA Lurain, R Ramaswami, LT Krug… - Clinical Microbiology …, 2024 - journals.asm.org
Within weeks of the first report of acquired immunodeficiency syndrome (AIDS) in 1981, it
was observed that these patients often had Kaposi sarcoma (KS), a hitherto rarely seen skin …

Double-hit B-cell lymphomas

SM Aukema, R Siebert, ED Schuuring… - Blood, The Journal …, 2011 - ashpublications.org
In many B-cell lymphomas, chromosomal translocations are biologic and diagnostic
hallmarks of disease. An intriguing subset is formed by the so-called double-hit (DH) …

Diffuse large B-cell lymphoma variants: an update

N Sukswai, K Lyapichev, JD Khoury, LJ Medeiros - Pathology, 2020 - Elsevier
Diffuse large B-cell lymphoma (DLBCL) is the most common type of lymphoma, representing
approximately one-third of all cases worldwide. In the World Health Organization (WHO) …

Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis and classification

G Ott, A Rosenwald, E Campo - Blood, The Journal of the …, 2013 - ashpublications.org
MYC is a potent oncogene initially identified as the target of the t (8; 14)(q24; q32)
chromosome translocation in Burkitt lymphoma. MYC gene alterations have been identified …

The role of c-MYC in B-cell lymphomas: diagnostic and molecular aspects

L Nguyen, P Papenhausen, H Shao - Genes, 2017 - mdpi.com
c-MYC is one of the most essential transcriptional factors, regulating a diverse array of
cellular functions, including proliferation, growth, and apoptosis. Dysregulation of c-MYC is …

Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta …

J Morscio, D Dierickx, J Nijs, G Verhoef… - The American Journal …, 2014 - journals.lww.com
Plasmablastic lymphoma (PBL) is a rare B-cell non-Hodgkin lymphoma often associated
with Epstein-Barr virus (EBV) infection. To gain insight in this aggressive lymphoma subtype …